Search
Selected: C

Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chimeric antibody against tumor associated antigens and its...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chimeric antibody with specificity to human B cell surface antig

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chimeric antibody with specificity to human B cell surface...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chimeric immunoglobulin for CD4 receptors

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chimeric infectious bursal disease virus cDNA clones, expression

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chimeric protein for prevention and treatment of HIV infection

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chimeric proteins with cell-targeting specificity and...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chimeric, human and humanized anti-CSAP monoclonal antibodies

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chimeric, human and humanized anti-granulocyte antibodies...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chlorine dioxide and quaternary ammonium salts as sterilizing ag

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Choline binding proteins for anti-pneumococcal vaccines

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chronic lymphocytic leukemia cell line

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chronic rheumatoid arthritis therapy containing IL-6 antagonist

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Claudogenic-interceptive nonapeptides

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Claudogenic-interceptive nonapeptides

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cloning and regulation of an endothelial cell protein...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cloning and regulation of an endothelial cell protein...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Clostridial toxin disease therapy

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Derived from – or present in – food product
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Clostridium difficile toxin disease therapy

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Derived from – or present in – food product
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.